hCTLA4-gene modified human bone marrow-derived mesenchymal stem cells as allogeneic seed cells in bone tissue engineering

Tissue Engineering

Volumn 12, Issue 9, 2006, Pages 2583-2590

  Dai, Fei ^a   Shi, Dongwen ^a   He, Weifeng ^a   Wu, Jun ^a,b   Luo, Gaoxin ^a,b   Yi, Shaoxuan ^a,b   Xu, Jianzhong ^a   Chen, Xiwei ^a,b  

^a SOUTHWEST HOSPITAL   (China)

^b Chongqing Key Laboratory of Ophthalmology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; BONE; CYTOLOGY; GENES; TOXICITY;

BONE MARROW; CYTOTOXIC; HETEROGENEIC SEED CELLS; MESENCHYMAL STEM CELLS; TISSUE ENGINEERING;

TISSUE CULTURE;

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGAND; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE TISSUE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; NONHUMAN; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; COCULTURE; CYTOLOGY; FISCHER 344 RAT; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METHODOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, INBRED F344; TISSUE ENGINEERING; TRANSDUCTION, GENETIC;

EID: 33750631901     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.2583     Document Type: Article

References (21)

1. Edelman, E.R. Vascular tissue engineering: designer arteries. Circ . Res. 85, 1115, 1999.
2. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
3. Friedenstein, A.J., Shapiro-Piatetzky, I.I., and Petrakova, K.V. Osteogenesis in transplants of bone marrow cells [J]. J. Embryol. Exp. Morphol. 16, 381, 1996.
4. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R.4. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
5. Deans, R.J., and Moseley, A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28, 875, 2000.
6. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42, 2002.
7. Lotze, M.T., and Finn, O.J. Recent advances in cellular immunology: implications for immunity to cancer. Immunol. Today 11, 190, 1990.
8. Carreno, B.M., Bennett, F., Chau, T.A., Ling, V., Luxenberg, D., Juson, J., Baroja, M.L., and Madrenas. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165, 1352, 2000.
9. Jaiswal, N., Haynesworth, S.E., Caplain, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64, 295, 1997.
10. He, W.F., Wu, J., Yi, S.X., Luo, G.X., Chen, X.W., Zhang, J.S., Ma, B., and Lei, X. Construction and identification of dicistronic retrovirus expression vector to coexpress human CTLA4Ig and EGFP genes. Acta Acad. Med. Militaris Tertiae 24, 782, 2002.
11. Dai, F., Wu, J., Chen, X.W., He, W.F., and Zhang, X.R. Comparison of transfection efficiency of Nucleofector™ and liposome transfection techniques for transfection of recombinant plasmid into PA317 cells. Acta Acad. Med. Militaris Tertiae 26, 104, 2004.
12. Wu, J., Barisoni, D., and Armato, U. Donor's and recipient's antigen presenting cells co-operatively enhance the alloreactive proliferation of peripheral blood lymphocyte. Life Sci. 54, 1009, 1994.
13. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Burder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64, 295, 1997.
14. Kasten, P., Luginbuhl, R., van-Griensven, M., Barkhausen, T., Krettek, C., Bohner, M., and Bosch, U. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials 24, 2593, 2003.
15. Lodie, T.A., Blickarz, C.E., Devarakonda, T.J., He, C., Ajeeta, B.D., Clarke, J., Gleneck, K., Shihabuddin, L., and Tubo, R. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 8, 739, 2002.
16. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42, 2002.
17. Tse, W.T., Pendleton, J.D., Beyer, W.M., Egalka, M.C., and Guinan, E.G. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389, 2003.
18. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57, 11, 2003.
19. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., and Jorgensen, C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837, 2003.
20. Maitra, B., Szekely, E., Gjini, K., Laughlin, M.J., Dennis, J., Haynesworth, S.E., and Koc, O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597, 2004.
21. Deans, R.J., and Moseley, A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28, 875, 2000.